{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:56:32Z","timestamp":1768560992486,"version":"3.49.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Pharos University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To date, COVID-19 continues to pose a global health challenge, with substantial morbidity, mortality, and long-term post-COVID-19 complications threatening public health resilience. During the early pandemic, the IL-6 inhibitor (tocilizumab) was the widely used approved immunotherapy for critically ill patients; however, a subset of ICU cases exhibited normal interleukin-6 (IL-6) levels and failed to respond. We hypothesized that interleukin-17 (IL-17), which acts synergistically with IL-6, contributes to cytokine storm progression and severe inflammation. Our study uniquely integrates a clinical cross-sectional analysis with advanced in-silico modelling, directly linking patient-derived biomarker, radiological, and statistical data to molecular-level mechanisms of COVID-19 severity. Serum IL-17 was significantly elevated in critical versus moderate COVID-19 cases, with a threshold of 187.9 ng\/mL predicting poor outcomes by ROC analysis. Logistic regression identified age and monocytes as independent predictors of severity, supporting a combined biomarker approach for improving the prognosis and clinical outcomes. Radiological findings, including ground-glass opacities and consolidations, alongside hematological abnormalities, were more frequent in critical cases. Computational docking revealed key amino acid residues\u2014particularly asparagine (Asn) and cysteine (Cys)\u2014as structural determinants shared by SARS-CoV-2 spike protein and human inflammatory mediators (IL-17R, IL-6R, CD41\/CD61, CD47\/SIRP). Asparaginase (ASNase) targeted critical residues such as the invariant gate residue \u201cAsn343\u201d and Cys213 of spike protein, Asn240 of IL-17R, and Asn136 of IL-6R. Several phytochemicals, including phytic acid and amygdalin, as well as synthetic agents such as candesartan, remdesivir, and enalapril, were found to preferentially bind to cysteine (Cys) residues\u2014and, to a lesser extent, asparagine (Asn) residues\u2014within key binding interfaces, in addition to targeting B-cell epitopes. This conserved residue preference supports the rationale for a dual-action therapeutic strategy in which asparaginase (ASNase) is combined with selected plant-derived ligands to simultaneously disrupt viral entry mechanisms and attenuate the inflammatory signalling. This dual-perspective approach not only identified IL-17 and IL-6 as independent severity predictors but also revealed conserved Asn and Cys motifs as critical therapeutic targets, leading to novel strategies\u2014such as ASNase, synthetic agents and phytochemical combinations\u2014for simultaneously blocking viral entry and modulating hyperinflammatory pathways. These findings warrant rigorous experimental and clinical validation to facilitate translation into effective therapeutic interventions.<\/jats:p>","DOI":"10.1038\/s41598-025-19359-y","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T15:13:57Z","timestamp":1762182837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting asparagine and cysteine in SARS-CoV-2 variants and human pro-inflammatory mediators to alleviate COVID-19 severity; a cross-section and in-silico study"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6696-0405","authenticated-orcid":false,"given":"Hewida H.","family":"Fadel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3145-2416","authenticated-orcid":false,"given":"Hadeer Adel","family":"EL-Esseily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6079-2984","authenticated-orcid":false,"given":"Mohammed Abd EL-Rahman","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Ahmed","family":"Khamis Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3659-3616","authenticated-orcid":false,"given":"Mohamed Nabil","family":"Roushdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8087-0898","authenticated-orcid":false,"given":"Amr","family":"ElSherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5553-8842","authenticated-orcid":false,"given":"Kareem Mahamoud","family":"Gharbeya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8107-9384","authenticated-orcid":false,"given":"Hadeel Said","family":"Abdelsalam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"19359_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9544-8_67-1","author":"AS Monto","year":"2024","unstructured":"Monto, A. S., Cowling, B. J. & Peiris, J. S. M. Coronaviruses: the common cold, SARS, and MERS. Viral Infect. Hum. https:\/\/doi.org\/10.1007\/978-1-4939-9544-8_67-1 (2024).","journal-title":"Viral Infect. Hum."},{"key":"19359_CR2","unstructured":"https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update-edition-177"},{"key":"19359_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.21608\/aeji.2025.372531.1463","volume":"15","author":"TH Attia","year":"2025","unstructured":"Attia, T. H. et al. Current COVID-19 situation in children: 2025 statement. Afro-Egyptian J. Infect. Endemic Dis. 15, 217\u2013225. https:\/\/doi.org\/10.21608\/aeji.2025.372531.1463 (2025).","journal-title":"Afro-Egyptian J. Infect. Endemic Dis."},{"key":"19359_CR4","doi-asserted-by":"publisher","first-page":"8155","DOI":"10.3390\/ijms25158155","volume":"25","author":"YS Chung","year":"2024","unstructured":"Chung, Y. S., Lam, C. Y., Tan, P. H. & Tsang, H. F. Sze-Chuen Cesar wong. Comprehensive review of COVID-19: epidemiology, pathogenesis, advancement in diagnostic and detection techniques, and Post-Pandemic treatment strategies. Int. J. Mol. Sci. 25, 8155\u20138155. https:\/\/doi.org\/10.3390\/ijms25158155 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"19359_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s42380-025-00296-3","author":"SD Walsh","year":"2025","unstructured":"Walsh, S. D. et al. COVID-19 school closures and peer violence in adolescents in 42 countries: evidence from the health behaviour in School-Aged children study. Int. J. Bullying Prev. https:\/\/doi.org\/10.1007\/s42380-025-00296-3 (2025). Advance online publication.","journal-title":"Int. J. Bullying Prev."},{"key":"19359_CR6","doi-asserted-by":"publisher","unstructured":"Moyo, T. & Tashu, K. T. Revenue Constraints on the Implementation of Sustainable Development Goals: COVID-19 Pandemic in Africa. Implementing the UN Sustainable Development Goals \u2013 Regional Perspectives 853\u2013870 (2024). https:\/\/doi.org\/10.1007\/978-3-031-17465-0_56","DOI":"10.1007\/978-3-031-17465-0_56"},{"key":"19359_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s43621-024-00526-6","author":"X Chen","year":"2024","unstructured":"Chen, X., Xu, Z. & Jiang, T. Impacts of COVID-19 on SDGs revealed by satellite remote sensing: a bibliometric analysis and systematic review. Discover Sustain. https:\/\/doi.org\/10.1007\/s43621-024-00526-6 (2024).","journal-title":"Discover Sustain."},{"key":"19359_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.matpr.2021.09.517","author":"R Fulzele","year":"2021","unstructured":"Fulzele, R., Fulzele, V. & Dharwal, M. Mapping the impact of COVID-19 crisis on the progress of sustainable Development Goals (SDGs)\u2014a focus on global environment and energy efficiencies. Mater. Today Proc. https:\/\/doi.org\/10.1016\/j.matpr.2021.09.517 (2021).","journal-title":"Mater. Today Proc."},{"key":"19359_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11239-024-03028-4","volume":"58","author":"RC Becker","year":"2025","unstructured":"Becker, R. C. et al. The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management. J. Thromb. Thrombolysis. 58, 15\u201349. https:\/\/doi.org\/10.1007\/s11239-024-03028-4 (2025).","journal-title":"J. Thromb. Thrombolysis"},{"key":"19359_CR10","doi-asserted-by":"publisher","first-page":"29634","DOI":"10.1038\/s41598-024-81028-3","volume":"14","author":"P Liang","year":"2024","unstructured":"Liang, P. et al. Prognostic significance of serum interleukin-6 in severe\/critical COVID-19 patients treated with tocilizumab: a detailed observational study analysis. Sci. Rep. 14, 29634. https:\/\/doi.org\/10.1038\/s41598-024-81028-3 (2024).","journal-title":"Sci. Rep."},{"key":"19359_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf5632","author":"J Fedry","year":"2021","unstructured":"Fedry, J. et al. Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11. Sci. Adv. https:\/\/doi.org\/10.1126\/sciadv.abf5632 (2021).","journal-title":"Sci. Adv."},{"key":"19359_CR12","doi-asserted-by":"publisher","first-page":"8244","DOI":"10.1074\/jbc.M009979200","volume":"276","author":"RL Moritz","year":"2001","unstructured":"Moritz, R. L., Hall, N. E., Connolly, L. M. & Simpson, R. J. Determination of the disulfide structure and N-Glycosylation sites of the extracellular domain of the human signal transducer gp130. J. Biol. Chem. 276, 8244\u20138253 (2001).","journal-title":"J. Biol. Chem."},{"key":"19359_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2880","author":"S Liu","year":"2013","unstructured":"Liu, S. et al. Crystal structures of interleukin 17A and its complex with IL-17 receptor A. Nat. Commun. https:\/\/doi.org\/10.1038\/ncomms2880 (2013).","journal-title":"Nat. Commun."},{"key":"19359_CR14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.molcel.2008.11.018","volume":"32","author":"J Zhu","year":"2008","unstructured":"Zhu, J. et al. Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol. Cell. 32, 849\u2013861 (2008).","journal-title":"Mol. Cell"},{"key":"19359_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.molcel.2008.05.026","volume":"31","author":"D Hatherley","year":"2008","unstructured":"Hatherley, D. et al. Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47. Mol. Cell. 31, 266\u2013277. https:\/\/doi.org\/10.1016\/j.molcel.2008.05.026 (2008).","journal-title":"Mol. Cell"},{"key":"19359_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33088-0","author":"LE Asif Shajahan, Pepi","year":"2023","unstructured":"Asif Shajahan, Pepi, L. E., Kumar, B., Murray, N. B. & Azadi, P. Site specific N- and O-glycosylation mapping of the spike proteins of SARS-CoV-2 variants of concern. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-023-33088-0 (2023).","journal-title":"Sci. Rep."},{"key":"19359_CR17","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41557-021-00758-3","volume":"13","author":"T Sztain","year":"2021","unstructured":"Sztain, T. et al. A glycan gate controls opening of the SARS-CoV-2 Spike protein. Nat. Chem. 13, 963\u2013968. https:\/\/doi.org\/10.1038\/s41557-021-00758-3 (2021).","journal-title":"Nat. Chem."},{"key":"19359_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-024-02434-1","author":"A Dariusz \u0141aszczych","year":"2024","unstructured":"Dariusz \u0141aszczych, A., Czernicka, Gostomczyk, K. & \u0141ukasz, S. The role of IL-17 in the pathogenesis and treatment of glioblastoma\u2014an update on the state of the art and future perspectives. Med. Oncol. https:\/\/doi.org\/10.1007\/s12032-024-02434-1 (2024).","journal-title":"Med. Oncol."},{"key":"19359_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41392-025-02198-8","volume":"10","author":"Y Tian","year":"2025","unstructured":"Tian, Y. et al. Platelets and diseases: signal transduction and advances in targeted therapy. Signal. Transduct. Target. Therapy. 10, 159. https:\/\/doi.org\/10.1038\/s41392-025-02198-8 (2025).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"19359_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.4049\/jimmunol.2001019","volume":"206","author":"G Andrejeva","year":"2021","unstructured":"Andrejeva, G. et al. Novel SIRP\u03b1 antibodies that induce Single-Agent phagocytosis of tumor cells while preserving T cells. J. Immunol. 206, 712\u2013721. https:\/\/doi.org\/10.4049\/jimmunol.2001019 (2021).","journal-title":"J. Immunol."},{"key":"19359_CR21","doi-asserted-by":"publisher","first-page":"e0232311","DOI":"10.1371\/journal.pone.0232311","volume":"15","author":"R Lieu","year":"2020","unstructured":"Lieu, R. et al. Rapid and robust antibody fab fragment crystallization utilizing edge-to-edge beta-sheet packing. PLOS ONE. 15, e0232311\u2013e0232311. https:\/\/doi.org\/10.1371\/journal.pone.0232311 (2020).","journal-title":"PLOS ONE"},{"key":"19359_CR22","doi-asserted-by":"publisher","first-page":"155932582210923","DOI":"10.1177\/15593258221092379","volume":"20","author":"A Aisha","year":"2022","unstructured":"Aisha, A. et al. Anticancer L-Asparaginase and phytoactive compounds from plant Solanum nigrum against MDR (Methicillindrug resistant) Staphylococcus aureus and fungal isolates. Dose-Response 20, 155932582210923 (2022).","journal-title":"Dose-Response"},{"key":"19359_CR23","volume-title":"Clinical guide to laboratory tests","author":"NW Tietz","year":"1995","unstructured":"Tietz, N. W. Clinical guide to laboratory tests 3rd edn. (WB saunders, 1995).","edition":"3"},{"key":"19359_CR24","volume-title":"Wintrobe\u2019s Clinical Hematology","author":"JP Greer","year":"2018","unstructured":"Greer, J. P. et al. Wintrobe\u2019s Clinical Hematology (Lippincott Williams & Wilkins, 2018)."},{"key":"19359_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/pro.70052","author":"GJ Bekker","year":"2025","unstructured":"Bekker, G. J. et al. Protein data bank Japan: Improved tools for sequence\u2010oriented analysis of protein structures. Protein Sci. https:\/\/doi.org\/10.1002\/pro.70052 (2025).","journal-title":"Protein Sci."},{"key":"19359_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/pro.3290","volume":"27","author":"F Sievers","year":"2017","unstructured":"Sievers, F. & Higgins, D. G. Clustal Omega for making accurate alignments of many protein sequences. Protein Sci. 27, 135\u2013145. https:\/\/doi.org\/10.1002\/pro.3290 (2017).","journal-title":"Protein Sci."},{"key":"19359_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2105-13-173","volume":"13","author":"MU Johansson","year":"2012","unstructured":"Johansson, M. U., Zoete, V., Michielin, O. & Guex, N. Defining and searching for structural motifs using DeepView\/Swiss-PdbViewer. BMC Bioinform. 13, 173 (2012).","journal-title":"BMC Bioinform."},{"key":"19359_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0708-4_9","author":"M Andrey Alekseenko, Ignatov","year":"2020","unstructured":"Andrey Alekseenko, Ignatov, M., Jones, G., Sabitova, M. & Kozakov, D. G. Protein\u2013protein and protein\u2013peptide docking with ClusPro server. Methods Mol. Biol. https:\/\/doi.org\/10.1007\/978-1-0716-0708-4_9 (2020).","journal-title":"Methods Mol. Biol."},{"key":"19359_CR29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/nar\/gkae270","volume":"52","author":"AM Waterhouse","year":"2024","unstructured":"Waterhouse, A. M. et al. The structure assessment web server: for proteins, complexes and more. Nucleic Acids Res. 52, 318\u2013323. https:\/\/doi.org\/10.1093\/nar\/gkae270 (2024).","journal-title":"Nucleic Acids Res."},{"key":"19359_CR30","doi-asserted-by":"publisher","first-page":"btw514","DOI":"10.1093\/bioinformatics\/btw514","volume":"32","author":"LC Xue","year":"2016","unstructured":"Xue, L. C., Rodrigues, J. P., Kastritis, P. L., Bonvin, A. M. & Vangone, A. PRODIGY: a web server for predicting the binding affinity of protein\u2013protein complexes. Bioinformatics 32, btw514. https:\/\/doi.org\/10.1093\/bioinformatics\/btw514 (2016).","journal-title":"Bioinformatics"},{"key":"19359_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-S1-S33","author":"KC Hsu","year":"2011","unstructured":"Hsu, K. C., Chen, Y. F., Lin, S. R. & Yang, J. M. iGEMDOCK: A graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis. BMC Bioinform. https:\/\/doi.org\/10.1186\/1471-2105-12-S1-S33 (2011).","journal-title":"BMC Bioinform."},{"key":"19359_CR32","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","volume":"45","author":"MC Jespersen","year":"2017","unstructured":"Jespersen, M. C., Peters, B., Nielsen, M. & Marcatili, P. BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 45, W24\u2013W29. https:\/\/doi.org\/10.1093\/nar\/gkx346 (2017).","journal-title":"Nucleic Acids Res."},{"key":"19359_CR33","unstructured":"Schoonjans, F. MedCalc statistical software. MedCalc Statistical Software version 23.0.8 (MedCalc Software Ltd, Ostend, Belgium; (2024). https:\/\/www.medcalc.org"},{"key":"19359_CR34","volume-title":"Atkins\u2019 Physical Chemistry","author":"W Atkins, Peter","year":"2018","unstructured":"Atkins, Peter, W. et al. Atkins\u2019 Physical Chemistry 11th edn. (Oxford University Press, 2018).","edition":"11"},{"key":"19359_CR35","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1007\/s13738-021-02233-9","volume":"18","author":"F Sadeghi","year":"2021","unstructured":"Sadeghi, F., Afkhami, A., Madrakian, T. & Ghavami, R. A new approach for simultaneous calculation of pIC50 and logp through QSAR\/QSPR modeling on anthracycline derivatives: a comparable study. J. Iran. Chem. Soc. 18, 2785\u20132800 (2021).","journal-title":"J. Iran. Chem. Soc."},{"key":"19359_CR36","doi-asserted-by":"publisher","first-page":"e47595","DOI":"10.2196\/47595","volume":"25","author":"W Jiao","year":"2023","unstructured":"Jiao, W. et al. Predicting and empowering health for generation Z by comparing health information seeking and digital health literacy: Cross-Sectional questionnaire study. J. Med. Internet. Res. 25, e47595. https:\/\/doi.org\/10.2196\/47595 (2023).","journal-title":"J. Med. Internet. Res."},{"key":"19359_CR37","doi-asserted-by":"publisher","first-page":"e17281","DOI":"10.7717\/peerj.17281","volume":"12","author":"H Mahmood","year":"2024","unstructured":"Mahmood, H., Furqan, M. & Muhammad Shahid Hassan. The effects of COVID-19 on agriculture supply chain, food security, and environment: a review. PeerJ 12, e17281\u2013e17281. https:\/\/doi.org\/10.7717\/peerj.17281 (2024).","journal-title":"PeerJ"},{"key":"19359_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-90918-z","author":"M Ghasemitarei","year":"2025","unstructured":"Ghasemitarei, M. et al. The effect of cysteine oxidation on conformational changes of SARS-CoV-2 spike protein using atomistic simulations. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-025-90918-z (2025).","journal-title":"Sci. Rep."},{"key":"19359_CR39","doi-asserted-by":"publisher","first-page":"nwae206","DOI":"10.1093\/nsr\/nwae206","volume":"11","author":"P Liu","year":"2024","unstructured":"Liu, P. et al. Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity. Natl. Sci. Rev. 11, nwae206. https:\/\/doi.org\/10.1093\/nsr\/nwae206 (2024).","journal-title":"Natl. Sci. Rev."},{"key":"19359_CR40","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cell.2020.09.032","volume":"183","author":"L Yurkovetskiy","year":"2020","unstructured":"Yurkovetskiy, L. et al. Structural and functional analysis of the D614G SARS-CoV-2 Spike protein variant. Cell 183, 739\u2013751e8. https:\/\/doi.org\/10.1016\/j.cell.2020.09.032 (2020).","journal-title":"Cell"},{"key":"19359_CR41","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s12015-021-10322-8","volume":"18","author":"Romy","year":"2022","unstructured":"Romy et al. SARS-CoV-2 infects red blood cell progenitors and dysregulates hemoglobin and iron metabolism. Stem Cell. Reviews Rep. 18, 1809\u20131821. https:\/\/doi.org\/10.1007\/s12015-021-10322-8 (2022).","journal-title":"Stem Cell. Reviews Rep."},{"key":"19359_CR42","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3390\/nu16152502","volume":"16","author":"A Tomasiewicz","year":"2024","unstructured":"Tomasiewicz, A. Jacek Pola\u0144ski & Wojciech ta\u0144ski. Advancing the Understanding of malnutrition in the elderly population: current insights and future directions. Nutrients 16, 2502\u20132502. https:\/\/doi.org\/10.3390\/nu16152502 (2024).","journal-title":"Nutrients"},{"key":"19359_CR43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41590-024-01754-8","volume":"25","author":"AL Hanson","year":"2024","unstructured":"Hanson, A. L. et al. Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19. Nat. Immunol. 25, 471\u2013482. https:\/\/doi.org\/10.1038\/s41590-024-01754-8 (2024).","journal-title":"Nat. Immunol."},{"key":"19359_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.706","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Analysis of deletional hereditary persistence of fetal hemoglobin\/\u03b4\u03b2-thalassemia and \u03b4\u2010globin gene mutations in Southerwestern China. Mol. Genet. Genom. Med. https:\/\/doi.org\/10.1002\/mgg3.706 (2019).","journal-title":"Mol. Genet. Genom. Med."},{"key":"19359_CR45","doi-asserted-by":"publisher","first-page":"21779","DOI":"10.1038\/s41598-020-78711-6","volume":"10","author":"CR Arbeitman","year":"2020","unstructured":"Arbeitman, C. R. et al. Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells. Sci. Rep. 10, 21779. https:\/\/doi.org\/10.1038\/s41598-020-78711-6 (2020).","journal-title":"Sci. Rep."},{"key":"19359_CR46","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.1007\/s00216-023-04771-y","volume":"415","author":"D Wang","year":"2023","unstructured":"Wang, D., Baudys, J., Osman, S. H. & Barr, J. R. Analysis of the N-glycosylation profiles of the Spike proteins from the alpha, beta, gamma, and delta variants of SARS-CoV-2. Anal. Bioanal. Chem. 415, 4779\u20134793. https:\/\/doi.org\/10.1007\/s00216-023-04771-y (2023).","journal-title":"Anal. Bioanal. Chem."},{"key":"19359_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/1348-0421.13121","volume":"68","author":"T Das","year":"2024","unstructured":"Das, T. et al. N-glycosylation of the SARS\u2010CoV\u20102 Spike protein at Asn331 and Asn343 is involved in Spike\u2010ACE2 binding, virus entry, and regulation of IL\u20106. Microbiol. Immunol. 68, 165\u2013178. https:\/\/doi.org\/10.1111\/1348-0421.13121 (2024).","journal-title":"Microbiol. Immunol."},{"key":"19359_CR48","doi-asserted-by":"publisher","first-page":"7052","DOI":"10.1038\/s41598-025-85153-5","volume":"15","author":"RL Cheng","year":"2025","unstructured":"Cheng, R. L. et al. Exploring the effects of N234 and N343 linked glycans to SARS CoV 2 Spike protein pocket accessibility using Gaussian accelerated molecular dynamics simulations. Sci. Rep. 15, 7052. https:\/\/doi.org\/10.1038\/s41598-025-85153-5 (2025).","journal-title":"Sci. Rep."},{"key":"19359_CR49","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01672-23","author":"F Zhang","year":"2024","unstructured":"Zhang, F. et al. SARS-CoV-2 Spike glycosylation affects function and neutralization sensitivity. MBio https:\/\/doi.org\/10.1128\/mbio.01672-23 (2024).","journal-title":"MBio"},{"key":"19359_CR50","doi-asserted-by":"publisher","first-page":"110383","DOI":"10.1016\/j.virol.2024.110383","volume":"604","author":"FR Hills","year":"2025","unstructured":"Hills, F. R., Geoghegan, J. L. & Bostina, M. Architects of infection: A structural overview of SARS-related coronavirus Spike glycoproteins. Virology 604, 110383. https:\/\/doi.org\/10.1016\/j.virol.2024.110383 (2025).","journal-title":"Virology"},{"key":"19359_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70242","author":"S Liu","year":"2025","unstructured":"Liu, S. et al. The compensatory effect of S375F on S371F is vital for maintaining the infectivity of SARS-CoV\u20102 omicron variants. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.70242 (2025).","journal-title":"J. Med. Virol."},{"key":"19359_CR52","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1182\/blood-2023-172591","volume":"142","author":"L Maese","year":"2023","unstructured":"Maese, L. et al. Real-World treatment patterns among patients with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL) who initiated an asparaginase treatment after the approval of Recombinant Erwinia (Rylaze). Blood 142, 7374\u20137374. https:\/\/doi.org\/10.1182\/blood-2023-172591 (2023).","journal-title":"Blood"},{"key":"19359_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29753","author":"C Matteo","year":"2022","unstructured":"Matteo, C. et al. Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l\u2010asparaginase product. Pediatr. Blood Cancer https:\/\/doi.org\/10.1002\/pbc.29753 (2022).","journal-title":"Pediatr. Blood Cancer"},{"key":"19359_CR54","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/08880018.2024.2395365","volume":"41","author":"C Cheng","year":"2024","unstructured":"Cheng, C., Dores, G. M., Nayernama, A., Jones, S. C. & Rabik, C. A. Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literature. Pediatr. Hematol. Oncol. 41, 519\u2013529. https:\/\/doi.org\/10.1080\/08880018.2024.2395365 (2024).","journal-title":"Pediatr. Hematol. Oncol."},{"key":"19359_CR55","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41598-024-83637-4","volume":"15","author":"M Alqaaf","year":"2025","unstructured":"Alqaaf, M. et al. Discovering natural products as potential inhibitors of SARS-CoV-2 Spike proteins. Sci. Rep. 15, 200. https:\/\/doi.org\/10.1038\/s41598-024-83637-4 (2025).","journal-title":"Sci. Rep."},{"key":"19359_CR56","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1038\/s41467-022-32665-7","volume":"13","author":"Z Zhao","year":"2022","unstructured":"Zhao, Z. et al. Omicron SARS-CoV-2 mutations stabilize Spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape. Nat. Commun. 13, 4958. https:\/\/doi.org\/10.1038\/s41467-022-32665-7 (2022).","journal-title":"Nat. Commun."},{"key":"19359_CR57","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abp9962","author":"Y Fang","year":"2022","unstructured":"Fang, Y. et al. An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif. Sci. Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.abp9962 (2022).","journal-title":"Sci. Immunol."},{"key":"19359_CR58","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s12325-022-02042-3","volume":"39","author":"L Villaescusa","year":"2022","unstructured":"Villaescusa, L. et al. A new approach to the management of COVID-19. Antagonists of IL-6: Siltuximab. Adv. Ther. 39, 1126\u20131148. https:\/\/doi.org\/10.1007\/s12325-022-02042-3 (2022).","journal-title":"Adv. Ther."},{"key":"19359_CR59","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s40121-021-00458-y","volume":"10","author":"F Zheng","year":"2021","unstructured":"Zheng, F. et al. Dynamic Changes in the Immune Response Correlate with Disease Severity and Outcomes During Infection with SARS-CoV-2. Infectious Diseases and Therapy 10, 1391\u20131405. https:\/\/doi.org\/10.1007\/s40121-021-00458-y (2021).","journal-title":"Infectious Diseases and Therapy"},{"key":"19359_CR60","doi-asserted-by":"crossref","unstructured":"Lin, I-Chun. et al. Involvement of IL-17 A\/IL-17 Receptor A with Neutrophil Recruitment and the Severity of Coronary Arteritis in Kawasaki Disease. Journal of Clinical Immunology 44,\u00a03. https:\/\/doi.org\/10.1007\/s10875-024-01673-1(2024).","DOI":"10.1007\/s10875-024-01673-1"},{"key":"19359_CR61","doi-asserted-by":"publisher","first-page":"8479","DOI":"10.1128\/JVI.00724-14","volume":"88","author":"W Hou","year":"2014","unstructured":"Hou, W., Jin, Y. H., Kang, H. S. & Kim, B. S. Interleukin-6 (IL-6) and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function. J. Virol. 88, 8479\u20138489. https:\/\/doi.org\/10.1128\/JVI.00724-14 (2014).","journal-title":"J. Virol."},{"key":"19359_CR62","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.immuni.2008.07.018","volume":"29","author":"H Ogura","year":"2008","unstructured":"Ogura, H. et al. Interleukin-17 promotes autoimmunity by triggering a Positive-Feedback loop via Interleukin-6 induction. Immunity 29, 628\u2013636. https:\/\/doi.org\/10.1016\/j.immuni.2008.07.018 (2008).","journal-title":"Immunity"},{"key":"19359_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-025-01565-7","author":"T Meng","year":"2025","unstructured":"Meng, T., Nie, L. & Wang, Y. Role of CD4\u2009+\u2009T cell-derived cytokines in the pathogenesis of uveitis. Clin. Exp. Med. https:\/\/doi.org\/10.1007\/s10238-025-01565-7 (2025).","journal-title":"Clin. Exp. Med."},{"key":"19359_CR64","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s86396","author":"SF Zhou","year":"2015","unstructured":"Zhou, S. F. & Chen, X. W. Inflammation, cytokines, the IL-17\/IL-6\/STAT3\/NF-\u03baB axis, and tumorigenesis. Drug. Des. Devel. Ther. https:\/\/doi.org\/10.2147\/dddt.s86396 (2015).","journal-title":"Drug. Des. Devel. Ther."},{"key":"19359_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1505-5","author":"BA Tannous","year":"2019","unstructured":"Tannous, B. A. & Badr, C. E. A TNF-NF-\u03baB-STAT3 loop triggers resistance of glioma-stem-like cells to Smac mimetics while sensitizing to EZH2 inhibitors. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-019-1505-5 (2019).","journal-title":"Cell Death Dis."},{"key":"19359_CR66","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ccell.2022.04.004","volume":"40","author":"Y Hailemichael","year":"2022","unstructured":"Hailemichael, Y. et al. Interleukin-6 Blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell. 40, 509\u2013523. https:\/\/doi.org\/10.1016\/j.ccell.2022.04.004 (2022). .e6.","journal-title":"Cancer Cell."},{"key":"19359_CR67","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7150\/ijbs.5996","volume":"9","author":"G Carbone","year":"2013","unstructured":"Carbone, G. et al. Interleukin-6 receptor Blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis. Int. J. Biol. Sci. 9, 279\u2013288. https:\/\/doi.org\/10.7150\/ijbs.5996 (2013).","journal-title":"Int. J. Biol. Sci."},{"key":"19359_CR68","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41577-020-0328-z","volume":"20","author":"O Pacha","year":"2020","unstructured":"Pacha, O., Sallman, M. A. & Evans, S. E. COVID-19: a case for inhibiting IL-17?. Nat. Rev. Immunol. 20, 345\u2013346. https:\/\/doi.org\/10.1038\/s41577-020-0328-z (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"19359_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96110-3","author":"MZ Hasan","year":"2021","unstructured":"Hasan, M. Z., Islam, S., Matsumoto, K. & Kawai, T. SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-021-96110-3 (2021).","journal-title":"Sci. Rep."},{"key":"19359_CR70","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ni.1813","volume":"10","author":"K Lauren","year":"2009","unstructured":"Lauren, K. & Ely, Fischer, S. Christopher garcia. Structural basis of receptor sharing by Interleukin 17 cytokines. Nat. Immunol. 10, 1245\u20131251. https:\/\/doi.org\/10.1038\/ni.1813 (2009).","journal-title":"Nat. Immunol."},{"key":"19359_CR71","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/cells13020107","volume":"13","author":"FG Hanisch","year":"2024","unstructured":"Hanisch, F. G. & Site-Specific O-glycosylation of SARS-CoV-2 Spike protein and its impact on immune and autoimmune responses. Cells 13, 107\u2013107. https:\/\/doi.org\/10.3390\/cells13020107 (2024).","journal-title":"Cells"},{"key":"19359_CR72","doi-asserted-by":"publisher","first-page":"e2000080","DOI":"10.1371\/journal.pbio.2000080","volume":"15","author":"S Riethmueller","year":"2017","unstructured":"Riethmueller, S. et al. Proteolytic origin of the soluble human IL-6R in vivo and a decisive role of N-Glycosylation. PLoS Biol. 15, e2000080. https:\/\/doi.org\/10.1371\/journal.pbio.2000080 (2017).","journal-title":"PLoS Biol."},{"key":"19359_CR73","doi-asserted-by":"publisher","first-page":"155654","DOI":"10.1016\/j.cyto.2021.155654","volume":"146","author":"T Korn","year":"2021","unstructured":"Korn, T. & Hiltensperger, M. Role of IL-6 in the commitment of T cell subsets. Cytokine 146, 155654 (2021).","journal-title":"Cytokine"},{"key":"19359_CR74","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1007\/s10787-024-01578-w","volume":"32","author":"H Sabit","year":"2024","unstructured":"Sabit, H. et al. Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants. Inflammopharmacol 32, 3631\u20133652. https:\/\/doi.org\/10.1007\/s10787-024-01578-w (2024).","journal-title":"Inflammopharmacol"},{"key":"19359_CR75","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s43046-025-00291-1","volume":"37","author":"N Bouhamdani","year":"2025","unstructured":"Bouhamdani, N. et al. Successful treatment of prolonged COVID-19 with Remdesivir and nirmatrelvir\/ritonavir in a patient with a history of diffuse large B-cell lymphoma: a case report. J. Egypt. Natl. Canc Inst. 37, 32. https:\/\/doi.org\/10.1186\/s43046-025-00291-1 (2025).","journal-title":"J. Egypt. Natl. Canc Inst."},{"key":"19359_CR76","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s13205-018-1282-3","volume":"8","author":"A Vimal","year":"2018","unstructured":"Vimal, A. & Kumar, A. l-Asparaginase: a feasible therapeutic molecule for multiple diseases. Biotech 8, 278. https:\/\/doi.org\/10.1007\/s13205-018-1282-3 (2018).","journal-title":"Biotech"},{"key":"19359_CR77","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1126\/science.1083901","volume":"300","author":"MJ Boulanger","year":"2003","unstructured":"Boulanger, M. J., Chow, D. C., Brevnova, E. E. & Garcia, K. C. Hexameric structure and assembly of the Interleukin-6\/IL-6-Receptor\/gp130 complex. Science 300, 2101\u20132104 (2003).","journal-title":"Science"},{"key":"19359_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69429-w","author":"K Li","year":"2024","unstructured":"Li, K. et al. Unveiling novel insights into human IL-6\u2009\u2013\u2009IL-6R interaction sites through 3D computer-guided docking and systematic site mutagenesis. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-024-69429-w (2024).","journal-title":"Sci. Rep."},{"key":"19359_CR79","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.3390\/ijms24076170","volume":"24","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q., Zhang, S., Chen, J. & Xie, Z. The interplay between integrins and immune cells as a regulator in cancer immunology. Int. J. Mol. Sci. 24, 6170\u20136170. https:\/\/doi.org\/10.3390\/ijms24076170 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"19359_CR80","doi-asserted-by":"publisher","first-page":"e1652540","DOI":"10.1080\/2162402X.2019.1652540","volume":"8","author":"J Chen","year":"2019","unstructured":"Chen, J. et al. Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients. OncoImmunology 8, e1652540\u2013e1652540. https:\/\/doi.org\/10.1080\/2162402X.2019.1652540 (2019).","journal-title":"OncoImmunology"},{"key":"19359_CR81","doi-asserted-by":"publisher","DOI":"10.21608\/ejchem.2021.100838.4685","author":"H Fadel","year":"2021","unstructured":"Fadel, H., Ahmed, M., Mohamed, M. & Almiry, R. Determination of the cut-off score of human platelets membrane glycoprotein iib\/iiia in COVID19: A novel biomarker and a therapeutic target. Egypt. J. Chem. https:\/\/doi.org\/10.21608\/ejchem.2021.100838.4685 (2021).","journal-title":"Egypt. J. Chem."},{"key":"19359_CR82","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature02976","volume":"432","author":"T Xiao","year":"2004","unstructured":"Xiao, T., Takagi, J., Coller, B. S., Wang, J. H. & Springer, T. A. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 432, 59\u201367. https:\/\/doi.org\/10.1038\/nature02976 (2004).","journal-title":"Nature"},{"key":"19359_CR83","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11739-021-02795-9","volume":"17","author":"H Luo","year":"2021","unstructured":"Luo, H. et al. Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19. Intern. Emerg. Med. 17, 153\u2013163. https:\/\/doi.org\/10.1007\/s11739-021-02795-9 (2021).","journal-title":"Intern. Emerg. Med."},{"key":"19359_CR84","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-021-01120-w","author":"D Cozzi","year":"2021","unstructured":"Cozzi, D. et al. Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19. Jpn. J. Radiol. https:\/\/doi.org\/10.1007\/s11604-021-01120-w (2021).","journal-title":"Jpn. J. Radiol."},{"key":"19359_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-023-00463-w","author":"H Xin","year":"2023","unstructured":"Xin, H. et al. Structure, signal transduction, activation, and inhibition of integrin \u03b1IIb\u03b23. Thromb. J. https:\/\/doi.org\/10.1186\/s12959-023-00463-w (2023).","journal-title":"Thromb. J."},{"key":"19359_CR86","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1161\/ATVBAHA.122.318904","volume":"43","author":"B Singla","year":"2023","unstructured":"Singla, B. et al. CD47 activation by Thrombospondin-1 in lymphatic endothelial cells suppresses lymphangiogenesis and promotes atherosclerosis. Arterioscler. Thromb. Vascular Biology. 43, 1234\u20131250. https:\/\/doi.org\/10.1161\/ATVBAHA.122.318904 (2023).","journal-title":"Arterioscler. Thromb. Vascular Biology"},{"key":"19359_CR87","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","volume":"52","author":"MEW Logtenberg","year":"2020","unstructured":"Logtenberg, M. E. W., Scheeren, F. A. & Schumacher, T. N. The CD47-SIRP\u03b1 immune checkpoint. Immunity 52, 742\u2013752. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.011 (2020).","journal-title":"Immunity"},{"key":"19359_CR88","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03856-6","author":"C Ma","year":"2025","unstructured":"Ma, C., Li, Y., Li, M., Lv, C. & Tian, Y. Targeting immune checkpoints on myeloid cells: current status and future directions. Cancer Immunol. Immunotherapy https:\/\/doi.org\/10.1007\/s00262-024-03856-6 (2025).","journal-title":"Cancer Immunol. Immunotherapy"},{"key":"19359_CR89","doi-asserted-by":"publisher","first-page":"100070","DOI":"10.1016\/j.iotech.2022.100070","volume":"13","author":"R Maute","year":"2022","unstructured":"Maute, R., Xu, J. & Weissman, I. L. CD47\u2013SIRP\u03b1-targeted therapeutics: status and prospects. Immuno-Oncology Technol. 13, 100070. https:\/\/doi.org\/10.1016\/j.iotech.2022.100070 (2022).","journal-title":"Immuno-Oncology Technol."},{"issue":"6","key":"19359_CR90","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1007\/s10787-023-01263-4","volume":"31","author":"MT Kelleni","year":"2023","unstructured":"Kelleni, M. T. The African kelleni\u2019s roadmap using Nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one. Inflammopharmacology 31 (6), 3335\u20133338. https:\/\/doi.org\/10.1007\/s10787-023-01263-4 (2023).","journal-title":"Inflammopharmacology"},{"key":"19359_CR91","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s10787-024-01475-2","volume":"32","author":"RM Garc\u00eda-\u00c1lvarez","year":"2024","unstructured":"Garc\u00eda-\u00c1lvarez, R. M. et al. Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient. Inflammopharmacology 32, 1805\u20131815. https:\/\/doi.org\/10.1007\/s10787-024-01475-2 (2024).","journal-title":"Inflammopharmacology"},{"key":"19359_CR92","doi-asserted-by":"publisher","first-page":"177832","DOI":"10.1016\/j.ejphar.2025.177832","volume":"1002","author":"HM Abdelaziz","year":"2025","unstructured":"Abdelaziz, H. M., Abdelmageed, M. E. & Suddek, G. M. Molsidomine ameliorates DEXA-induced insulin resistance: involvement of HMGB1\/JAK1\/STAT3 signaling pathway. Eur. J. Pharmacol. 1002, 177832. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177832 (2025).","journal-title":"Eur. J. Pharmacol."},{"key":"19359_CR93","doi-asserted-by":"publisher","first-page":"7981","DOI":"10.3390\/ijms25147981","volume":"25","author":"A Ol\u00e1h","year":"2024","unstructured":"Ol\u00e1h, A. et al. A comparative investigation of the pulmonary vasodilating effects of inhaled NO gas therapy and inhalation of a new drug formulation containing a NO donor metabolite (SIN-1A). Int. J. Mol. Sci. 25, 7981. https:\/\/doi.org\/10.3390\/ijms25147981 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"19359_CR94","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/jn\/137.1.135","volume":"137","author":"LV Miller","year":"2007","unstructured":"Miller, L. V., Krebs, N. F. & Hambidge, K. M. A mathematical model of zinc absorption in humans as a function of dietary zinc and phytate. J. Nutr. 137, 135\u2013141. https:\/\/doi.org\/10.1093\/jn\/137.1.135 (2007).","journal-title":"J. Nutr."},{"key":"19359_CR95","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1107\/s0907444902019443","volume":"59","author":"J Lubkowski","year":"2002","unstructured":"Lubkowski, J., Dauter, M., Aghaiypour, K., Wlodawer, A. & Dauter, Z. Atomic resolution structure of Erwinia chrysanthemiL-asparaginase. Acta Crystallogr. Sect. D Biol. Crystallogr. 59, 84\u201392. https:\/\/doi.org\/10.1107\/s0907444902019443 (2002).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"19359_CR96","doi-asserted-by":"publisher","first-page":"176156","DOI":"10.1016\/j.ejphar.2023.176156","volume":"960","author":"Y Pan","year":"2023","unstructured":"Pan, Y. et al. Bisabosqual A: A novel asparagine synthetase inhibitor suppressing the proliferation and migration of human non-small cell lung cancer A549 cells. Eur. J. Pharmacol. 960, 176156. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176156 (2023).","journal-title":"Eur. J. Pharmacol."},{"key":"19359_CR97","doi-asserted-by":"publisher","first-page":"20220944","DOI":"10.1515\/biol-2022-0944","volume":"19","author":"A Aouadi","year":"2024","unstructured":"Aouadi, A. et al. Chemical composition\u2019s effect on Solanum nigrum linn.\u2018s antioxidant capacity and erythrocyte protection: bioactive components and molecular Docking analysis. Open. Life Sci. 19, 20220944. https:\/\/doi.org\/10.1515\/biol-2022-0944 (2024).","journal-title":"Open. Life Sci."},{"key":"19359_CR98","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-022-04654","author":"D Sharma","year":"2023","unstructured":"Sharma, D. et al. Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate. Mol. Cell. Biochem. https:\/\/doi.org\/10.1007\/s11010-022-04654 (2023).","journal-title":"Mol. Cell. Biochem."},{"key":"19359_CR99","doi-asserted-by":"publisher","DOI":"10.29219\/fnr.v65.5623","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. The mechanism and active compounds of semen armeniacae amarum treating coronavirus disease 2019 based on network pharmacology and molecular docking. Food Nutr. Res. https:\/\/doi.org\/10.29219\/fnr.v65.5623 (2021).","journal-title":"Food Nutr. Res."},{"key":"19359_CR100","doi-asserted-by":"publisher","first-page":"e250667","DOI":"10.1590\/1519-6984.25066","volume":"84","author":"MT Khan","year":"2022","unstructured":"Khan, M. T. et al. Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study. Braz J. Biol. 84, e250667. https:\/\/doi.org\/10.1590\/1519-6984.25066 (2022).","journal-title":"Braz J. Biol."},{"key":"19359_CR101","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2022.11200","author":"M Hagiyama","year":"2022","unstructured":"Hagiyama, M. et al. Indigo plant leaf extract inhibits the binding of SARSCoV-2 spike protein to angiotensinconverting enzyme 2. Exp. Therap. Med. https:\/\/doi.org\/10.3892\/etm.2022.11200 (2022).","journal-title":"Exp. Therap. Med."},{"key":"19359_CR102","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.22038\/ijbms.2024.77203.16693","volume":"27","author":"KG Ibrahim","year":"2024","unstructured":"Ibrahim, K. G. et al. Thymoquinone: A comprehensive review of its potential role as a monotherapy for metabolic syndrome. PubMed 27, 1214\u20131227. https:\/\/doi.org\/10.22038\/ijbms.2024.77203.16693 (2024).","journal-title":"PubMed"},{"key":"19359_CR103","doi-asserted-by":"publisher","first-page":"100902","DOI":"10.1016\/j.hermed.2024.100902","volume":"46","author":"M \u00d6zkan","year":"2024","unstructured":"\u00d6zkan, M. & G\u00fcne\u015f, H. Do the natural and herbal remedies used for fighting against COVID-19 pose a risk for surgical patients? J. Herb. Med. 46, 100902 (2024).","journal-title":"J. Herb. Med."},{"key":"19359_CR104","doi-asserted-by":"publisher","first-page":"110929","DOI":"10.1016\/j.foodres.2021.110929","volume":"153","author":"B Luiza Koop","year":"2022","unstructured":"Luiza Koop, B. et al. Flavonoids, anthocyanins, betalains, curcumin, and carotenoids: sources, classification and enhanced stabilization by encapsulation and adsorption. Food Res. Int. 153, 110929. https:\/\/doi.org\/10.1016\/j.foodres.2021.110929 (2022).","journal-title":"Food Res. Int."},{"key":"19359_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-024-02695-x","author":"C Lai","year":"2024","unstructured":"Lai, C. et al. Efficiency of combination therapy versus monotherapy for the treatment of infections due to carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis. Syst. Rev. https:\/\/doi.org\/10.1186\/s13643-024-02695-x (2024).","journal-title":"Syst. Rev."},{"key":"19359_CR106","doi-asserted-by":"publisher","first-page":"100167","DOI":"10.1016\/j.crphar.2023.100167","volume":"6","author":"Suhail Ahmad","year":"2024","unstructured":"Suhail Ahmad et al. Flavonoids as promising molecules in the cancer therapy: an insight. Curr. Res. Pharmacol. Drug Discovery. 6, 100167\u2013100167. https:\/\/doi.org\/10.1016\/j.crphar.2023.100167 (2024).","journal-title":"Curr. Res. Pharmacol. Drug Discovery"},{"key":"19359_CR107","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s40262-021-01090-2","volume":"61","author":"DJ Angiolillo","year":"2022","unstructured":"Angiolillo, D. J. et al. Pharmacokinetic and pharmacodynamic profile of a novel phospholipid aspirin formulation. Clin. Pharmacokinet. 61, 465\u2013479. https:\/\/doi.org\/10.1007\/s40262-021-01090-2 (2022).","journal-title":"Clin. Pharmacokinet."},{"key":"19359_CR108","doi-asserted-by":"publisher","first-page":"101046","DOI":"10.1016\/j.cegh.2022.101046","volume":"15","author":"N Nimavat","year":"2022","unstructured":"Nimavat, N. et al. Is it time to re-evaluate SDGs in the light of COVID-19 pandemic? Clin. Epidemiol. Global Health. 15, 101046. https:\/\/doi.org\/10.1016\/j.cegh.2022.101046 (2022).","journal-title":"Clin. Epidemiol. Global Health"},{"key":"19359_CR109","doi-asserted-by":"publisher","first-page":"1670015","DOI":"10.1080\/16549716.2019.1670015","volume":"12","author":"T Alfv\u00e9n","year":"2019","unstructured":"Alfv\u00e9n, T. et al. Placing children and adolescents at the centre of the sustainable development goals will deliver for current and future generations. Global Health Action. 12, 1670015. https:\/\/doi.org\/10.1080\/16549716.2019.1670015 (2019).","journal-title":"Global Health Action"},{"key":"19359_CR110","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41541-025-01161-6","volume":"10","author":"L Kulakova","year":"2025","unstructured":"Kulakova, L. et al. Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicity. Npj Vaccines. 10, 121. https:\/\/doi.org\/10.1038\/s41541-025-01161-6 (2025).","journal-title":"Npj Vaccines"},{"key":"19359_CR111","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s10930-023-10132-6","volume":"42","author":"Z Sheik Ismail","year":"2023","unstructured":"Sheik Ismail, Z. et al. HIV protease hinge region insertions at codon 38 affect enzyme kinetics, conformational stability and dynamics. Protein J. 42, 490\u2013501. https:\/\/doi.org\/10.1007\/s10930-023-10132-6 (2023).","journal-title":"Protein J."},{"issue":"1","key":"19359_CR112","doi-asserted-by":"publisher","first-page":"115168","DOI":"10.1016\/j.celrep.2024.115168","volume":"44","author":"C Sun","year":"2025","unstructured":"Sun, C. et al. Structural basis of Epstein-Barr virus gp350 receptor recognition and neutralization. Cell. Rep. 44 (1), 115168. https:\/\/doi.org\/10.1016\/j.celrep.2024.115168 (2025).","journal-title":"Cell. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19359-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:45:16Z","timestamp":1762231516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19359-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19359"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19359-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all subjects involved in our study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript has been read and approved for submission by all the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"38445"}}